Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does KANAMYCIN\KANAMYCIN A Cause Condition aggravated? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Condition aggravated have been filed in association with KANAMYCIN\KANAMYCIN A. This represents 3.8% of all adverse event reports for KANAMYCIN\KANAMYCIN A.

6
Reports of Condition aggravated with KANAMYCIN\KANAMYCIN A
3.8%
of all KANAMYCIN\KANAMYCIN A reports
2
Deaths
3
Hospitalizations

How Dangerous Is Condition aggravated From KANAMYCIN\KANAMYCIN A?

Of the 6 reports, 2 (33.3%) resulted in death, 3 (50.0%) required hospitalization, and 4 (66.7%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for KANAMYCIN\KANAMYCIN A. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does KANAMYCIN\KANAMYCIN A Cause?

Drug resistance (38) Tuberculosis (21) Vomiting (21) Anaemia (18) Neuropathy peripheral (18) Arthralgia (15) Nausea (15) Electrocardiogram qt prolonged (14) Nephropathy toxic (12) Off label use (12)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which KANAMYCIN\KANAMYCIN A Alternatives Have Lower Condition aggravated Risk?

KANAMYCIN\KANAMYCIN A vs KARDEGIC KANAMYCIN\KANAMYCIN A vs KEPPRA KANAMYCIN\KANAMYCIN A vs KETAMINE KANAMYCIN\KANAMYCIN A vs KETOCONAZOLE KANAMYCIN\KANAMYCIN A vs KETOPROFEN

Related Pages

KANAMYCIN\KANAMYCIN A Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated KANAMYCIN\KANAMYCIN A Demographics